The Autoimmune Association of South Africa (AASA) has urged the South African medical schemes regulator, the Council for Medical Schemes (CMS), to provide clear guidelines regarding the extent to which medical schemes are required to cover expensive specialised treatments that are not commonly available in the public healthcare system. AASA’s executive director, Catherine McCormack, highlighted the ongoing struggles of dozens…